JP2013507429A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013507429A5 JP2013507429A5 JP2012533648A JP2012533648A JP2013507429A5 JP 2013507429 A5 JP2013507429 A5 JP 2013507429A5 JP 2012533648 A JP2012533648 A JP 2012533648A JP 2012533648 A JP2012533648 A JP 2012533648A JP 2013507429 A5 JP2013507429 A5 JP 2013507429A5
- Authority
- JP
- Japan
- Prior art keywords
- aerosol formulation
- suspension aerosol
- fluticasone propionate
- formoterol fumarate
- micrograms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0918150.4 | 2009-10-16 | ||
| GBGB0918150.4A GB0918150D0 (en) | 2009-10-16 | 2009-10-16 | Improved formulations |
| PCT/EP2010/065569 WO2011045429A1 (en) | 2009-10-16 | 2010-10-15 | Improved formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015191177A Division JP2016040286A (ja) | 2009-10-16 | 2015-09-29 | 改善された製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013507429A JP2013507429A (ja) | 2013-03-04 |
| JP2013507429A5 true JP2013507429A5 (enExample) | 2015-05-21 |
| JP5818801B2 JP5818801B2 (ja) | 2015-11-18 |
Family
ID=41462451
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012533648A Active JP5818801B2 (ja) | 2009-10-16 | 2010-10-15 | 改善された製剤 |
| JP2015191177A Pending JP2016040286A (ja) | 2009-10-16 | 2015-09-29 | 改善された製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015191177A Pending JP2016040286A (ja) | 2009-10-16 | 2015-09-29 | 改善された製剤 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20120263766A1 (enExample) |
| EP (2) | EP2488157B1 (enExample) |
| JP (2) | JP5818801B2 (enExample) |
| CN (1) | CN102573791B (enExample) |
| AU (1) | AU2010305695B2 (enExample) |
| BR (1) | BR112012008969B1 (enExample) |
| CA (1) | CA2776845C (enExample) |
| CL (1) | CL2012000948A1 (enExample) |
| CY (1) | CY1123918T1 (enExample) |
| DK (1) | DK2488157T3 (enExample) |
| ES (1) | ES2859629T3 (enExample) |
| GB (1) | GB0918150D0 (enExample) |
| HR (1) | HRP20210379T1 (enExample) |
| HU (1) | HUE054030T2 (enExample) |
| IL (2) | IL219162A0 (enExample) |
| LT (1) | LT2488157T (enExample) |
| MX (1) | MX372991B (enExample) |
| NZ (1) | NZ599900A (enExample) |
| PL (1) | PL2488157T3 (enExample) |
| PT (1) | PT2488157T (enExample) |
| RS (1) | RS61430B1 (enExample) |
| SI (1) | SI2488157T1 (enExample) |
| SM (1) | SMT202100150T1 (enExample) |
| WO (1) | WO2011045429A1 (enExample) |
| ZA (1) | ZA201202595B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040101483A1 (en) * | 2001-03-30 | 2004-05-27 | Rudi Muller-Walz | Medical aerosol formulations |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0918150D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved formulations |
| GB0918149D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| JP6335798B2 (ja) * | 2012-02-28 | 2018-05-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規噴射剤含有チオトロピウム製剤 |
| MX2014011576A (es) * | 2012-04-11 | 2014-11-21 | Cipla Ltd | Composicion farmaceutica. |
| GB201321712D0 (en) * | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Dry Powder Inhaler |
| CN105963282B (zh) * | 2016-05-04 | 2019-04-19 | 四川普锐特医药科技有限责任公司 | 一种医用定量吸入气雾剂 |
| CN109789107B (zh) * | 2016-09-29 | 2021-12-03 | 广东东阳光药业有限公司 | 药物组合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596260B1 (en) | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
| DE69637257T2 (de) | 1995-04-14 | 2008-06-12 | Smithkline Beecham Corp. | Verfahren zur Herstellung eines Dosierinhalators |
| DE69634865D1 (de) | 1995-04-14 | 2005-07-21 | Smithkline Beecham Corp | Dosierinhalator für Salmeterol |
| JPH101442A (ja) * | 1996-06-12 | 1998-01-06 | Taisho Pharmaceut Co Ltd | 鼻炎用点鼻薬 |
| EP0969816B1 (en) * | 1997-03-20 | 2004-12-15 | Schering Corporation | Preparation of powder agglomerates |
| GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
| CN1213732C (zh) * | 2000-05-22 | 2005-08-10 | 奇斯药制品公司 | 用于加压计量吸入器的稳定药用溶液制剂 |
| WO2002024552A2 (en) | 2000-09-18 | 2002-03-28 | Glaxo Group Limited | Coated can for a metered dose inhaler |
| PL199420B1 (pl) * | 2000-10-09 | 2008-09-30 | 3M Innovative Properties Co | Medyczne preparaty aerozolowe |
| US20040101483A1 (en) * | 2001-03-30 | 2004-05-27 | Rudi Muller-Walz | Medical aerosol formulations |
| US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| GB0201400D0 (en) * | 2002-01-22 | 2002-03-13 | Glaxo Group Ltd | Novel apparatus and process |
| EP1531866A1 (en) * | 2002-08-29 | 2005-05-25 | Cipla Ltd. | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| GB0323684D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| GB0327727D0 (en) * | 2003-11-28 | 2003-12-31 | Quadrant Drug Delivery Ltd | Viral microparticles |
| GB0410399D0 (en) * | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| GB0918150D0 (en) * | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved formulations |
-
2009
- 2009-10-16 GB GBGB0918150.4A patent/GB0918150D0/en not_active Ceased
-
2010
- 2010-10-15 SI SI201032050T patent/SI2488157T1/sl unknown
- 2010-10-15 SM SM20210150T patent/SMT202100150T1/it unknown
- 2010-10-15 NZ NZ599900A patent/NZ599900A/en unknown
- 2010-10-15 JP JP2012533648A patent/JP5818801B2/ja active Active
- 2010-10-15 BR BR112012008969-2A patent/BR112012008969B1/pt active IP Right Grant
- 2010-10-15 LT LTEP10768760.0T patent/LT2488157T/lt unknown
- 2010-10-15 HR HRP20210379TT patent/HRP20210379T1/hr unknown
- 2010-10-15 WO PCT/EP2010/065569 patent/WO2011045429A1/en not_active Ceased
- 2010-10-15 US US13/502,097 patent/US20120263766A1/en not_active Abandoned
- 2010-10-15 EP EP10768760.0A patent/EP2488157B1/en active Active
- 2010-10-15 PL PL10768760T patent/PL2488157T3/pl unknown
- 2010-10-15 AU AU2010305695A patent/AU2010305695B2/en active Active
- 2010-10-15 RS RS20210159A patent/RS61430B1/sr unknown
- 2010-10-15 CN CN201080046305.6A patent/CN102573791B/zh active Active
- 2010-10-15 ES ES10768760T patent/ES2859629T3/es active Active
- 2010-10-15 PT PT107687600T patent/PT2488157T/pt unknown
- 2010-10-15 CA CA2776845A patent/CA2776845C/en active Active
- 2010-10-15 EP EP20213235.3A patent/EP3811928A1/en not_active Withdrawn
- 2010-10-15 HU HUE10768760A patent/HUE054030T2/hu unknown
- 2010-10-15 MX MX2012004338A patent/MX372991B/es active IP Right Grant
- 2010-10-15 DK DK10768760.0T patent/DK2488157T3/da active
-
2012
- 2012-04-11 ZA ZA2012/02595A patent/ZA201202595B/en unknown
- 2012-04-13 CL CL2012000948A patent/CL2012000948A1/es unknown
- 2012-04-15 IL IL219162A patent/IL219162A0/en unknown
-
2015
- 2015-09-29 JP JP2015191177A patent/JP2016040286A/ja active Pending
-
2017
- 2017-03-21 US US15/464,879 patent/US20180296468A2/en not_active Abandoned
-
2019
- 2019-09-15 IL IL26936919A patent/IL269369A/en unknown
-
2021
- 2021-03-05 CY CY20211100190T patent/CY1123918T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013507429A5 (enExample) | ||
| AU2003260754B2 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| JP5809985B2 (ja) | ４−｛（１ｒ）−２−［（６−｛２−［（２，６−ジクロロベンジル）オキシ］エトキシ｝ヘキシル）アミノ］−１−ヒドロキシエチル｝−２−（ヒドロキシメチル）フェノールを含む医薬製剤 | |
| AU2025204271A1 (en) | Microcrystalline diketopiperazine compositions and methods | |
| CA2796934A1 (en) | Process for providing particles with reduced electrostatic charges | |
| JP2015519356A5 (enExample) | ||
| HRP20201711T1 (hr) | Postupci liječenja autoimunih, respiratornih i upalnih poremećaja inhalacijom roflumilast n-oksida | |
| CN102573791B (zh) | 改进的制剂 | |
| HRP20221431T1 (hr) | Formulacija suhog praška koja sadrži antikolinergik, kortikosteroid i beta-adrenergik za davanje inhalacijom | |
| JP6653324B2 (ja) | 乾燥粉末製剤 | |
| CA2948574A1 (en) | Combinations of formoterol and budesonide for the treatment of copd | |
| JP3691459B2 (ja) | 粉末状吸入剤組成物 | |
| HRP20160630T1 (hr) | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata | |
| US20130104881A1 (en) | Stabilized Metered Dose Inhaler | |
| EP2821061B1 (en) | Novel inhalation formulations | |
| IL167009A (en) | Dry powder formoterol or its derivatives for inhalation | |
| JP2005536538A (ja) | 薬学的組成物 | |
| MY187442A (en) | A pharmaceutical composition containing budesonide and formoterol | |
| EP2957552B1 (en) | Vilanterol formulations | |
| CN118510492A (zh) | 包含沙丁胺醇的药物组合物 | |
| JP2011509936A5 (enExample) | ||
| JP2011509936A (ja) | 吸入薬物製品、システムおよび使用 | |
| TW202525298A (zh) | 一種吸入性醫藥製劑、裝置及其用途 | |
| WO2024085820A1 (en) | A packaging technique for dry powder inhaler | |
| JP2006516531A (ja) | 吸入組成物 |